BioCentury
ARTICLE | Company News

Cellect Biomed, Accellta deal

April 25, 2016 7:00 AM UTC

Cellect granted Accellta non-exclusive rights to evaluate apoptotic induction-based technology. Accellta will evaluate if the technology can grow its pluripotent stem cells “safely and in a shorter ti...